SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
Public ClinicalTrials.gov record NCT00985725. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults With Clinically Significant, Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy of SPD489 for the treatment of executive function impairments (EFI) when used as an adjunct to stable, standard therapy in the setting of partial or full remission from recurrent Major Depressive Disorder (MDD) as measured by the Global Executive Composite (GEC) T-score of the Behavioral Rating Inventory of Executive Functioning - Adult Version (BRIEF-A).
Study identification
- NCT ID
- NCT00985725
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 143 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2009 (Actual)
- Primary completion
- Apr 18, 2011 (Actual)
- Completion
- Apr 18, 2011 (Actual)
- Last update posted
- Jun 8, 2021
2009 – 2011
United States locations
- U.S. sites
- 33
- U.S. states
- 15
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sun Valley Research Center | Imperial | California | 92251 | — |
| Pharmacology Research Center | Los Alamitos | California | 90720 | — |
| Excell Research | Oceanside | California | 92056 | — |
| Neuropsychiatric Resesarch Center of Orange County | Santa Ana | California | 92701 | — |
| Connecticut Clincal Research | Cromwell | Connecticut | 06416 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32216 | — |
| Amit Vijapura, MD | Jacksonville | Florida | 32256 | — |
| Scientific Clinical Research, Inc. | North Miami | Florida | 33161 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32806 | — |
| Atlanta Institute of Medicine & Research | Atlanta | Georgia | 30328 | — |
| Carman Research | Smyrna | Georgia | 30080 | — |
| Joliet Center for Clinical Research | Joliet | Illinois | 60435 | — |
| Capstone Clinical Research | Libertyville | Illinois | 60048 | — |
| Psychiatric Associates | Overland Park | Kansas | 66211 | — |
| AccelRx Research | Fall River | Massachusetts | 02721 | — |
| St. Charles Psychiatric Associates | Saint Charles | Missouri | 63301 | — |
| PsychCare Consultants Research | St Louis | Missouri | 63128 | — |
| Premier Psychiatric Research Institute, LLC | Lincoln | Nebraska | 68510 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10312 | — |
| North Carolina Neuropsychiatry, PA | Chapel Hill | North Carolina | 27514 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Richard H. Weisler, MD, PA & Associates | Raleigh | North Carolina | 27609 | — |
| Patient Priority Clinical Sites, LLC | Cincinnati | Ohio | 45242 | — |
| Lehigh Center for Clinical Research | Allentown | Pennsylvania | 18104 | — |
| Paramount Clinical Research | Bridgeville | Pennsylvania | 15017 | — |
| Suburban Research Associates | Media | Pennsylvania | 19063 | — |
| FutureSearch Trials of Dallas, LP | Dallas | Texas | 75231 | — |
| Bayou City Resesarch, LTD | Houston | Texas | 77007 | — |
| Red Oak Psychiatry Associates, PA | Houston | Texas | 77090 | — |
| University Hills Clinical Research | Irving | Texas | 75062 | — |
| R/D Clinical Research, Inc. | Lake Jackson | Texas | 77566 | — |
| Wharton Research Center | Wharton | Texas | 77488 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00985725, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2021 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00985725 live on ClinicalTrials.gov.